MAK Capital Fund LP

13F Holdings History for Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

Symbol: AUTL on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Latest Disclosed Ownership: 26.9M shares
Security Ownership: 10.1%

MAK Capital Fund LP ownership in Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

2025-12-03 - MAK Capital Fund LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 26.9M shares of Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL). This represents 10.1% percent ownership of the company. In their previous filing dated 2025-06-25, MAK Capital Fund LP had reported owning 15.4M shares, indicating an increase of 74.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
MAK Capital Fund LP	10.1%	+71.7%	$34.4M	26.9M	+11,478,870	+74.5%	$1.28	13G/A	12/1/2025	3 Dec 2025 16:04:15
MAK Capital Fund LP	5.8%		$19.6M	15.4M			$1.27	13G	6/17/2025	25 Jun 2025 18:36:35